1. CMT-3. CollaGenex. Fingleton B (2003) Curr Opin Investig Drugs 4(12): 1460-7
    › Primary publication · 14763133 (PubMed)
  2. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Coussens LM, Fingleton B, Matrisian LM (2002) Science 295(5564): 2387-92
    › Primary publication · 11923519 (PubMed)
  3. Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo. Vargo-Gogola T, Fingleton B, Crawford HC, Matrisian LM (2002) Cancer Res 62(19): 5559-63
    › Primary publication · 12359768 (PubMed)
  4. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM (2002) Arch Biochem Biophys 408(2): 155-61
    › Primary publication · 12464266 (PubMed)
  5. The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Crawford HC, Fingleton B, Gustavson MD, Kurpios N, Wagenaar RA, Hassell JA, Matrisian LM (2001) Mol Cell Biol 21(4): 1370-83
    › Primary publication · 11158322 (PubMed) · PMC99589 (PubMed Central)
  6. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. Noƫ V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M (2001) J Cell Sci 114(Pt 1): 111-118
    › Primary publication · 11112695 (PubMed)
  7. Matrix metalloproteinases as targets for therapy in Kaposi sarcoma. Fingleton B, Matrisian LM (2001) Curr Opin Oncol 13(5): 368-73
    › Primary publication · 11555714 (PubMed)
  8. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM (2001) Neoplasia 3(6): 459-68
    › Primary publication · 11774028 (PubMed) · PMC1506562 (PubMed Central)
  9. Matrix metalloproteinases: biologic activity and clinical implications. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) J Clin Oncol 18(5): 1135-49
    › Primary publication · 10694567 (PubMed)
  10. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM (2000) J Clin Invest 105(2): 143-50
    › Primary publication · 10642592 (PubMed) · PMC377426 (PubMed Central)